NUVB
Nuvation Bio Inc.
+0.34 (+5.97%)6.13USD2.5M成交股數2.2B市值–本益比(近四季)12.7股價營收比+555.6%營收年增(近四季)2026-11-02下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 4 · 2.1M · 4 |
| 其中 10b5-1 計畫賣出 | 4 筆 |
| 近 180 天 買進 · 賣出金額 | 118K · 3.5M |
| 近 180 天 淨額 | −3.3M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 | 08-21 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M 選擇權執行 | 100K | 1.87 | 187K | 100K | SEC |
| 2026-08-19 | 08-21 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 100K | 7.09 | 709K | 0 | SEC |
| 2026-07-15 | 07-17 | Sauvage Philippe | Chief Financial Officer | M 選擇權執行 | 1 | 1.97 | 1.97 | 54.1K | SEC |
| 2026-07-15 | 07-17 | Sauvage Philippe | Chief Financial Officer | M 選擇權執行 | 40.0K | 2.17 | 87K | 54.1K | SEC |
| 2026-06-23 | 06-24 | Wentworth Kerry | CHIEF REGULATORY OFFICER | M 選擇權執行 | 63.0K | 2.93 | 185K | 116K | SEC |
| 2026-06-23 | 06-24 | Markel Stacy | CHIEF PEOPLE OFFICER | M 選擇權執行 | 90.4K | 1.87 | 169K | 123K | SEC |
| 2026-06-23 | 06-24 | Wentworth Kerry | CHIEF REGULATORY OFFICER | S 公開市場賣出(10b5-1) | 63.0K | 6.02 | 379K | 53.0K | SEC |
| 2026-06-23 | 06-24 | Sauvage Philippe | Chief Financial Officer | S 公開市場賣出(10b5-1) | 47.7K | 6.01 | 286K | 12.7K | SEC |
| 2026-06-23 | 06-24 | Sauvage Philippe | Chief Financial Officer | M 選擇權執行 | 47.7K | 2.17 | 103K | 60.3K | SEC |
| 2026-06-23 | 06-24 | Markel Stacy | CHIEF PEOPLE OFFICER | S 公開市場賣出(10b5-1) | 125K | 6.03 | 754K | 32.6K | SEC |
| 2026-06-23 | 06-24 | Markel Stacy | CHIEF PEOPLE OFFICER | M 選擇權執行 | 34.6K | 1.74 | 60K | 158K | SEC |
| 2026-06-09 | 06-11 | Mashal Robert | Director | P 公開市場買進 | 25.0K | 4.73 | 118K | 225K | SEC |
| 2026-04-17 | 04-21 | Liu Dongfang | CHIEF MEDICAL OFFICER | M 選擇權執行 | 50.0K | 1.94 | 97K | 68.0K | SEC |
| 2026-04-17 | 04-21 | Wentworth Kerry | CHIEF REGULATORY OFFICER | S 公開市場賣出(10b5-1) | 36.8K | 5.01 | 184K | 53.0K | SEC |
| 2026-04-17 | 04-21 | Wentworth Kerry | CHIEF REGULATORY OFFICER | M 選擇權執行 | 36.8K | 2.93 | 108K | 89.8K | SEC |
| 2026-04-17 | 04-21 | Liu Dongfang | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 50.0K | 5.02 | 251K | 18.0K | SEC |
| 2026-04-06 | 04-08 | Wentworth Kerry | CHIEF REGULATORY OFFICER | M 選擇權執行 | 100K | 1.87 | 187K | 153K | SEC |
| 2026-04-06 | 04-08 | Wentworth Kerry | CHIEF REGULATORY OFFICER | M 選擇權執行 | 100K | 1.94 | 194K | 253K | SEC |
| 2026-04-06 | 04-08 | Wentworth Kerry | CHIEF REGULATORY OFFICER | S 公開市場賣出(10b5-1) | 200K | 4.52 | 904K | 53.0K | SEC |
| 2026-02-27 | 03-03 | Makunje Moses | SEE REMARKS | A 獲配股票 | 50.8K | – | – | 68.1K | SEC |
| 2025-12-01 | 12-03 | Liu Dongfang | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 150K | 7.82 | 1.2M | 18.0K | SEC |
| 2025-12-01 | 12-03 | Liu Dongfang | CHIEF MEDICAL OFFICER | M 選擇權執行 | 150K | 2.93 | 440K | 168K | SEC |
| 2025-11-26 | 11-26 | Liu Dongfang | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 10.0K | 8.00 | 80K | 18.0K | SEC |
| 2025-11-26 | 11-26 | Liu Dongfang | CHIEF MEDICAL OFFICER | M 選擇權執行 | 10.0K | 3.61 | 36K | 28.0K | SEC |
| 2025-11-25 | 11-26 | Liu Dongfang | CHIEF MEDICAL OFFICER | M 選擇權執行 | 10.0K | 3.61 | 36K | 28.0K | SEC |
| 2025-11-25 | 11-26 | Liu Dongfang | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 10.0K | 7.50 | 75K | 18.0K | SEC |
| 2025-11-20 | 11-24 | Liu Dongfang | CHIEF MEDICAL OFFICER | M 選擇權執行 | 20.0K | 1.87 | 37K | 38.0K | SEC |
| 2025-11-20 | 11-24 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M 選擇權執行 | 300K | 1.94 | 582K | 300K | SEC |
| 2025-11-20 | 11-24 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 69.1K | 7.23 | 499K | 0 | SEC |
| 2025-11-20 | 11-24 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 300K | 7.23 | 2.2M | 0 | SEC |
| 2025-11-20 | 11-24 | Liu Dongfang | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 20.0K | 7.00 | 140K | 18.0K | SEC |
| 2025-11-20 | 11-24 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M 選擇權執行 | 69.1K | 1.74 | 120K | 69.1K | SEC |
| 2025-11-19 | 11-21 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | M 選擇權執行 | 200K | 1.87 | 374K | 224K | SEC |
| 2025-11-19 | 11-21 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | S 公開市場賣出 | 200K | 7.14 | 1.4M | 24.0K | SEC |
| 2025-11-19 | 11-19 | Liu Dongfang | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 15.0K | 5.10 | 77K | 18.0K | SEC |
| 2025-11-19 | 11-19 | Liu Dongfang | CHIEF MEDICAL OFFICER | M 選擇權執行 | 15.0K | 1.87 | 28K | 30.0K | SEC |
| 2025-11-17 | 11-19 | Liu Dongfang | CHIEF MEDICAL OFFICER | M 選擇權執行 | 15.0K | 1.87 | 28K | 30.0K | SEC |
| 2025-11-17 | 11-19 | Liu Dongfang | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 15.0K | 4.77 | 72K | 15.0K | SEC |
| 2025-10-27 | 10-29 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 100K | 5.02 | 502K | 0 | SEC |
| 2025-10-27 | 10-29 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M 選擇權執行 | 100K | 1.74 | 174K | 100K | SEC |
| 2025-06-18 | 06-18 | Markel Stacy | CHIEF PEOPLE OFFICER | P 公開市場買進 | 10.0K | 1.71 | 17K | 29.6K | SEC |
| 2025-06-17 | 06-18 | Sauvage Philippe | Chief Financial Officer | P 公開市場買進 | 4.0K | 1.79 | 7K | 9.9K | SEC |
| 2025-06-16 | 06-18 | Hung David | PRESIDENT AND CEO | P 公開市場買進 | 500K | 1.79 | 895K | 59.3M | SEC |
| 2025-06-16 | 06-18 | Sauvage Philippe | Chief Financial Officer | P 公開市場買進 | 3.3K | 1.84 | 6K | 5.9K | SEC |
| 2025-06-16 | 06-18 | Sjogren Colleen | Chief Commercial Officer | P 公開市場買進 | 50.0K | 1.81 | 91K | 81.0K | SEC |
| 2025-06-16 | 06-18 | Wentworth Kerry | CHIEF REGULATORY OFFICER | P 公開市場買進 | 24.0K | 1.80 | 43K | 50.0K | SEC |
| 2025-06-16 | 06-18 | Wentworth Kerry | CHIEF REGULATORY OFFICER | P 公開市場買進 | 26.0K | 1.79 | 47K | 26.0K | SEC |
| 2025-05-02 | 05-06 | Liu Dongfang | CHIEF MEDICAL OFFICER | M 選擇權執行 | 20.0K | 1.94 | 39K | 32.0K | SEC |
| 2025-05-02 | 05-06 | Liu Dongfang | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 20.0K | 2.50 | 50K | 12.0K | SEC |
| 2025-04-07 | 04-08 | Hung David | PRESIDENT AND CEO | P 公開市場買進 | 300K | 1.63 | 489K | 58.8M | SEC |
| 2025-04-04 | 04-08 | Hung David | PRESIDENT AND CEO | P 公開市場買進 | 200K | 1.66 | 332K | 58.5M | SEC |
| 2025-04-01 | 04-03 | Mashal Robert | Director | P 公開市場買進 | 98.9K | 1.67 | 165K | 200K | SEC |
| 2025-04-01 | 04-03 | Mashal Robert | Director | P 公開市場買進 | 1.1K | 1.67 | 2K | 101K | SEC |
| 2024-11-11 | 11-13 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | S 公開市場賣出 | 56.4K | 2.89 | 163K | 3.9M | SEC |
| 2024-10-08 | 10-10 | Mashal Robert | Director | P 公開市場買進 | 100.0K | 2.20 | 220K | 100K | SEC |
| 2024-10-08 | 10-10 | Mashal Robert | Director | P 公開市場買進 | 19 | 2.20 | 41.80 | 19 | SEC |
| 2024-09-04 | 09-05 | Cui Xiangmin | Director | C 轉換 | 12.9M | – | – | 17.1M | SEC |
| 2024-09-04 | 09-05 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C 轉換 | 1.7M | – | – | 2.2M | SEC |
| 2024-09-04 | 09-05 | Cui Xiangmin | Director | C 轉換 | 5.2M | – | – | 7.6M | SEC |
| 2024-09-04 | 09-05 | Cui Xiangmin | Director | C 轉換 | 967K | – | – | 1.3M | SEC |
| 2024-09-04 | 09-05 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C 轉換 | 2.5M | – | – | 3.9M | SEC |
| 2024-06-25 | 06-26 | Cui Xiangmin | Director | P 公開市場買進 | 278K | 2.97 | 825K | 2.5M | SEC |
| 2024-06-24 | 06-25 | Cui Xiangmin | Director | P 公開市場買進 | 337K | 2.98 | 1.0M | 2.2M | SEC |
| 2024-06-21 | 06-25 | Cui Xiangmin | Director | P 公開市場買進 | 75.4K | 3.00 | 226K | 1.8M | SEC |
| 2024-06-20 | 06-25 | Cui Xiangmin | Director | P 公開市場買進 | 87.7K | 2.99 | 262K | 1.8M | SEC |
| 2024-06-11 | 06-13 | BLICKENSTAFF KIM D | Director | P 公開市場買進 | 172K | 2.90 | 499K | 172K | SEC |
| 2024-05-24 | 05-29 | WELCH DANIEL G | Director | M 選擇權執行 | 367K | 1.64 | 601K | 660K | SEC |
| 2024-05-24 | 05-29 | WELCH DANIEL G | Director | M 選擇權執行 | 293K | 1.74 | 510K | 293K | SEC |
| 2024-04-09 | 04-11 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A 獲配股票 | 1.4M | – | – | 1.4M | SEC |
| 2024-04-09 | 04-11 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A 獲配股票 | 551K | – | – | 551K | SEC |
| 2024-04-09 | 04-11 | Cui Xiangmin | Director | A 獲配股票 | 4.2M | – | – | 4.2M | SEC |
| 2024-04-09 | 04-11 | Cui Xiangmin | Director | A 獲配股票 | 1.7M | – | – | 1.7M | SEC |
| 2024-04-09 | 04-11 | Cui Xiangmin | Director | A 獲配股票 | 314K | – | – | 314K | SEC |
| 2023-09-21 | 09-22 | EcoR1 Venture Opportunity Fund, LP | Director | P 公開市場買進 | 53.0K | 1.36 | 72K | 12.7M | SEC |
| 2023-09-21 | 09-22 | EcoR1 Capital Fund, L.P. | Director | P 公開市場買進 | 53.0K | 1.36 | 72K | 12.7M | SEC |
| 2023-09-21 | 09-22 | NODELMAN OLEG | Director | P 公開市場買進 | 53.0K | 1.36 | 72K | 12.7M | SEC |
| 2023-09-21 | 09-22 | EcoR1 Capital, LLC | Director | P 公開市場買進 | 53.0K | 1.36 | 72K | 12.7M | SEC |
| 2023-09-21 | 09-22 | EcoR1 Capital Fund Qualified, L.P. | Director | P 公開市場買進 | 53.0K | 1.36 | 72K | 12.7M | SEC |
| 2023-09-21 | 09-22 | Biotech Opportunity GP, LLC | Director | P 公開市場買進 | 53.0K | 1.36 | 72K | 12.7M | SEC |
| 2023-09-20 | 09-22 | EcoR1 Capital, LLC | Director | P 公開市場買進 | 117K | 1.36 | 159K | 12.6M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 52.2M | 297M | 新進 | 新進 |
| BlackRock, Inc. | 27.6M | 157M | 新進 | 新進 |
| Decheng Capital LLC | 26.0M | 147M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.9M | 67.7M | 新進 | 新進 |
| Omega Fund Management, LLC | 8.1M | 45.9M | 新進 | 新進 |
| Laurion Capital Management LP | 7.8M | 44.4M | 新進 | 新進 |
| STATE STREET CORP | 7.4M | 41.9M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 6.2M | 35.5M | 新進 | 新進 |
| AMERICAN CENTURY COMPANIES INC | 4.5M | 25.6M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 3.5M | 20.0M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 3.3M | 18.7M | 新進 | 新進 |
| Redmile Group, LLC | 3.0M | 17.2M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.7M | 15.3M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 2.4M | 13.4M | 新進 | 新進 |
| NORTHERN TRUST CORP | 2.3M | 13.2M | 新進 | 新進 |
| ALGERT GLOBAL LLC | 2.3M | 12.9M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.1M | 11.7M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 2.0M | 11.6M | 新進 | 新進 |
| ARMISTICE CAPITAL, LLC | 2.0M | 11.4M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 2.0M | 11.3M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.9M | 10.8M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 1.8M | 10.1M | 新進 | 新進 |
| Connor, Clark & Lunn Investment Management Ltd. | 1.8M | 10.0M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.6M | 9.2M | 新進 | 新進 |
| Knoll Capital Management, LLC | 1.6M | 9.1M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 244 +11 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 244 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 233M · 66.5% |
| 合計季末市值 | 1.3B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 54.3M |
|---|---|
| 與上期比 | +2.0% |
| 佔流通股數 | 15.45% |
| 日均成交量 | 5.1M |
| 回補天數 | 10.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 54.3M | +2.0% | 15.45% | 5.1M | 10.7 |
| 2026-08-14 | 53.2M | -0.4% | 15.16% | 6.0M | 8.9 |
| 2026-07-31 | 53.4M | -4.0% | 15.22% | 6.1M | 8.7 |
| 2026-07-15 | 55.7M | +2.4% | 15.85% | 6.9M | 8.0 |
| 2026-06-30 | 54.4M | +11.1% | 15.48% | 11.7M | 4.6 |
| 2026-06-15 | 48.9M | -8.8% | 13.93% | 5.1M | 9.6 |
| 2026-05-29 | 53.7M | +4.2% | 15.29% | 3.7M | 14.4 |
| 2026-05-15 | 51.5M | +1.7% | 14.66% | 5.2M | 10.0 |
| 2026-04-30 | 50.6M | +0.7% | 14.42% | 3.9M | 13.0 |
| 2026-04-15 | 50.3M | +3.2% | 14.32% | 2.6M | 19.0 |
| 2026-03-31 | 48.7M | -1.4% | 13.88% | 3.6M | 13.4 |
| 2026-03-13 | 49.5M | +5.5% | 14.08% | 6.9M | 7.1 |
| 2026-02-27 | 46.9M | -4.0% | 13.35% | 4.3M | 10.9 |
| 2026-02-13 | 48.8M | -0.2% | 13.91% | 5.0M | 9.8 |
| 2026-01-30 | 48.9M | +2.0% | 13.93% | 5.9M | 8.4 |
| 2026-01-15 | 48.0M | +14.9% | 13.66% | 6.9M | 6.9 |
| 2025-12-31 | 41.7M | -9.2% | 11.89% | 5.6M | 7.5 |
| 2025-12-15 | 46.0M | -12.6% | 13.09% | 6.3M | 7.3 |
| 2025-11-28 | 52.6M | -20.7% | 14.98% | 14.5M | 3.6 |
| 2025-11-14 | 66.3M | -2.0% | 18.90% | 8.2M | 8.1 |
| 2025-10-31 | 67.7M | -14.5% | 19.28% | 9.9M | 6.8 |
| 2025-10-15 | 79.2M | +10.1% | 22.56% | 6.5M | 12.1 |
| 2025-09-30 | 72.0M | +5.8% | 20.50% | 6.9M | 10.4 |
| 2025-09-15 | 68.0M | -0.2% | 19.37% | 8.9M | 7.6 |
| 2025-08-29 | 68.1M | -1.4% | 19.40% | 4.5M | 15.2 |
| 2025-08-15 | 69.1M | -1.1% | 19.67% | 4.8M | 14.3 |